Nectar Lifesciences is a research driven pharmaceutical organization, engaged in manufacturing and delivering pharmaceutical products. Nectar Lifesciences CEO and director said the Japanese audit is one of the
In the first part, Biotron has dosed around 12 patients in the center, dddmag.com reported. Patients were divided according to the dosing of the drug, in which one-third
Emergent‘s income from operations was $34.96m for the fourth quarter of 2010, compared to $4.13m for the same period in 2009. The net income attributable to the company
Spencer Pharmaceutical said the patents are related to platform technologies for the efficient delivery of nucleic acids using chitosan as well as for an innovative discovery of therapeutic
Under this program, Jasco Pharma and NCCU are expected to combine the biological platform, tools and expertise at NCCU in the laboratory of Antonio Baines with Jasco Pharma’s
The multicentre, randomized, double-masked, sham injection-controlled, 36-month trial involved 377 patients with DME, who were randomised to receive monthly injections of either 0.3mg Lucentis (n=125), 0.5mg Lucentis (n=125)
The study results showed that adding aflibercept to the chemotherapy drug docetaxel did not meet the pre-specified criteria for primary endpoint, which was defined as improvement in overall
The Kinston facility, which manufactures syringe plungers and other components of intravenous (IV) systems, has around 325 workers. The Lionville, Pennsylvania-based firm intends to upgrade the Kinston plant
This Phase I award offers Avaxia a sum of around $145,000 in research and development funds. Avaxia founder and CEO Barbara Fox said they are delighted to have
The ATAGI recommendations for Fluvax vaccine are consistent with the 2011 product information, which states that children under five years of age should not receive Fluvax vaccine. In
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.